Abstract

Non-Hodgkin lymphoma is a diverse group of diseases. They can range from indolent lymphomas that patients can live with for years without treatment to highly aggressive lymphomas with high 5-year mortality rates. When considering a diagnosis of lymphoma it is important to obtain a core needle or excisional biopsy as fine needle aspiration often leads to inconclusive results and a delay in diagnosis. Risk stratifying patients and initiating treatment when necessary is vital to the initial investigation of a patient with a new diagnosis of lymphoma. Emerging therapies and ongoing clinical trials continue to improve outcomes for this patient population.

Original languageEnglish
Title of host publicationOncology
Publisherwiley
Pages342-353
Number of pages12
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
DOIs
StatePublished - 30 Aug 2019

Keywords

  • Aggressive lymphoma
  • B-cell lymphoma
  • BCR signaling
  • Cutaneous lymphoma
  • Immunochemotherapy
  • Indolent lymphoma
  • Non-Hodgkin lymphoma
  • Radiation
  • T-cell lymphoma

Fingerprint

Dive into the research topics of 'Non-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this